JHS Svendgaard Laboratories Share Price Today

JHS Svendgaard AGM passes all resolutions; scrutinizer report filed

All three ordinary resolutions at JHS Svendgaard's 22nd AGM passed with requisite majority. Total votes polled across resolutions stood at 30,484,569, representing 34.88% of outstanding shares. Adoption of FY26 standalone and consolidated financial statements received 99.99986% assent. Appointment of Paramvir Singh as director received 99.99795% assent with 625 votes against.

JHS Svendgaard Labs dispatches FY26 annual report, AGM notice

JHS Svendgaard Laboratories dispatched its FY26 Annual Report and 22nd AGM notice via web-links and QR codes. The virtual AGM is scheduled for September 26, 2026, at 3:00 pm. E-voting opens on September 23, 2026, and closes on September 25, 2026. Shareholders are reminded to update KYC details per SEBI Master Circular dated May 7, 2024. A special window for re-lodging physical share transfers runs until February 4, 2027.

JHS Svendgaard Laboratories schedules 22nd AGM for September 26

JHS Svendgaard Laboratories holds its 22nd AGM on September 26, 2026, via VC/OAVM. Remote e-voting runs from September 23 to September 25, 2026. Agenda includes adopting FY26 standalone and consolidated financial statements. Executive Director Paramvir Singh seeks reappointment by rotation.

JHS Svendgaard turns profitable in Q1FY26 on revenue surge

JHS Svendgaard Laboratories reported a Q1FY26 standalone net profit of ₹109.15 lakh, up from a ₹356.56 lakh loss in Q4FY25. Revenue rose 29.5% to ₹3,038.05 lakh. Consolidated net profit was ₹109.04 lakh. The turnaround was driven by operational efficiency and deferred tax credits, despite rising material costs.

JHS Svendgaard shareholders approve fund modification with 99.9% support

JHS Svendgaard Laboratories shareholders approved a special resolution to modify the utilization of funds raised through a preferential issue of equity shares and fully convertible warrants. The resolution passed on July 29, 2026, with 99.89% of votes cast in favor, granting the company strategic flexibility to reallocate capital.

JHS Svendgaard seeks fund use revision via postal ballot

JHS Svendgaard Laboratories Limited has initiated a postal ballot process to seek shareholder approval for revising the utilization of proceeds from a preferential issue. The total amount of ₹2,999.99 lakh remains unchanged, but the allocation is shifted towards capital expenditure, business expansion, and strategic growth initiatives by March 31, 2027. The remote e-voting period is open from June 30, 2026, to July 29, 2026.